You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Reliability Centered Additive Manufacturing Design Framework

    SBC: SENTIENT SCIENCE CORPORATION            Topic: N152109

    To address U.S. Navy needs, Sentient proposes to establish a Design Framework for reliability assurance of additive manufactured (AM) parts using their DigitalCloneTM Component (DCC) software. The framework will be tailored to metal components built through AM processes with complex geometries. Sensors are embedded during AM component build to allow for exploitation of sensor data, physics-based m ...

    SBIR Phase I 2016 Department of DefenseNavy
  2. Collision-Avoidance Radar for Small UAS

    SBC: UAVradars LLC            Topic: A202

    In the near future unmanned aircraft systems (UAS) will be utilized for many societal and commercial applications. However, the hurdle of operation safety in the form of avoiding airborne collisions must first be overcome. UAVradars LLC is proposing a small, lightweight, and low-power radar system designed specifically to give small UAS (< 55 lbs) airborne collision-avoidance sensory capability. ...

    SBIR Phase II 2016 National Aeronautics and Space Administration
  3. SBIR Phase II: Novel enzymes for producing homogeneous preparations of individual, monounsaturated industrial fatty acids

    SBC: VariFAS Biorenewables LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development and scale-up of a manufacturing platform for producing bio-based chemicals for application in lubricants. This manufacturing platform will utilize biologically derived sugar carbon-source and transform this carbon to higher value products via microbial fermentation. In cont ...

    SBIR Phase II 2016 National Science Foundation
  4. Secure Protocol Unalterable Data (SPUD)

    SBC: IDAHO SCIENTIFIC LLC            Topic: MDA15009

    Idaho Scientific proposes to design and develop, SPUD, an irrefutable tamper logging protocol.During the course of this Phase I effort, Idaho Scientific will implement the core of the logging protocol and develop a set of unit tests designed to evaluate properties of that protocol that uphold its irrefutable claims. During a Phase II effort, Idaho Scientific would propose to encapsulate this proto ...

    SBIR Phase I 2016 Department of DefenseMissile Defense Agency
  5. Robust 2700 F MC/C Fiber Reinforced Matrices for Turbine Engines

    SBC: ADVANCED CERAMIC FIBERS, L.L.C.            Topic: N141074

    Advanced Ceramic Fibers, LLC (ACF) completed the Navy SBIR Phase I Base Program and clearly demonstrated the feasibility of our approach to create a truly robust composite for turbine engines that exceeds the known boundaries for ceramic composites and the Navy performance objectives for this Topic. Our engineered materials approach involved in-depth background experience in ceramic matrix composi ...

    SBIR Phase II 2016 Department of DefenseNavy
  6. Development of an Osteoinductive Spinal Fusion Implant for Enhanced Fusion Rates

    SBC: EVOKE MEDICAL LLC            Topic: NIAMS

    DESCRIPTION provided by applicant The objective of this Phase I STTR research is to develop and test osteoinductive lumbar spinal fusion implant prototypes made using materials technology developments discovered by the PI at the University of Kansas In preliminary work lower impedance piezoelectric composite materials that generate power for direct current DC electrical stimulation applica ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing

    SBC: AXOSIM, INC.            Topic: NCATS

    DESCRIPTION provided by applicant The drug development pipeline is plagued by unacceptable rates of attrition due in large part to toxicities that are not identified in pre clincal stages of development The ability to de risk lead compounds during pre clinical development with advanced andquot organoid on a chipandquot technologies show tremendous promise Chemotherapeutics in particular whi ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Production of Image Guided Metastatic Melanoma Therapy Radiopharmaceuticals

    SBC: VIEWPOINT MOLECULAR TARGETING, INC.            Topic: 102

    DESCRIPTION provided by applicant Melanoma the fastest growing cancer incidence in the world today and the American Cancer Society reports that death rates for melanoma continue to rise Alarmingly melanoma is the most common cancer in young adults under One characteristic of metastatic melanoma cells that is recognized as a potential target for new therapies is upregulation of cell surfac ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Phase I Clinical trial with Demethyl cholesteryloxycarbonylpenclomedine DM CHOC PEN in Children with Cancer Involving the CNS

    SBC: DEKK-TEC INC            Topic: 102

    DESCRIPTION provided by applicant The primary goal of this Phase I pediatric oncology clinical trial will be to evaluate the safety and use of demethyl cholesteryloxycarbonylpenclomedine DM CHOC PEN as anticancer therapy for children with advanced cancer involving the central nervous system CNS DM CHOC PEN is a polychlorinated pyridine cholesteryloxycarbonate that crosses the blood br ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy

    SBC: EMMYON, INC.            Topic: NIAMS

    DESCRIPTION provided by applicant Skeletal muscle atrophy is a highly prevalent condition caused by advanced age muscle disuse chronic illness critical illness and malnutrition In addition to being very common muscle atrophy has serious consequences including weakness reduced activity and quality of life falls fractures extended hospitalizatio and rehabilitation nursing home placem ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government